January 09, 2025

curATime is looking for partners!

curATime is looking for partners!
Go back

The curATime cluster is one of 14 pioneering “Clusters4Future” initiatives funded by the German Federal Ministry of Education and Research (BMBF). Its mission is to promote personalized approaches to combat atherothrombosis-related diseases and to establish the Rhine-Main-Palatinate region as an international driver of innovation.

For the planned second implementation phase, the cluster is seeking new partners from science and industry who share its passion for revolutionary research in the field of cardiovascular diseases. It welcomes companies and institutions that can complement its existing expertise in artificial intelligence and mRNA technology and wish to actively contribute to the success of the cluster.

The curATime cluster aims to develop the next generation of medical solutions and revolutionise patient care!
Contact them for more information:

curatime@tron-mainz.de
curATime Cluster – Werden Sie Partner!Download

Our latest News

discover more
EMBL Council announces next EMBL Director General

EMBL Council announces next EMBL Director General

Anthony A. Hyman’s mandate to commence 31 March 2026 At its winter meeting, EMBL Council selected Anthony A. Hyman as EMBL’s next Director General.  “I am pleased to announce the decision by the EMBL Council to elect Anthony Hyman as future EMBL Director General,” said Peter Becker, EMBL Council Chair. “Tony witnessed the spirit of […]

read more
SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform

SPT Labtech enables automated PacBio Kinnex full-length RNA-seq library preparation workflow on SPT’s firefly platform

Cambridge, UK, 20 November 2025: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, today announced a collaboration with Pacific Biosciences (PacBio), a pioneer in long-read sequencing, to automate PacBio’s Kinnex™ full-length RNA-seq library preparation on SPT Labtech’s firefly® liquid handling platform. The automated workflow will improve reproducibility […]

read more
Ovesco takes the next step in metabolic bariatric endoscopy and invests in Transduodenal Concepts

Ovesco takes the next step in metabolic bariatric endoscopy and invests in Transduodenal Concepts

Ovesco Endoscopy AG from Tübingen is investing almost € 1 million in the company Trans-Duodenal Concepts GmbH, Mannheim, to jointly promote innovative solutions in the field of metabolic-bariatric endoscopy. Around one billion people worldwide are affected by metabolic syndrome and its manifestations such as obesity, diabetes, hypertension and fatty liver disease. The Mannheim-based start-up Trans-Duodenal […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp